methylprednisolone and Scleroderma, Diffuse

methylprednisolone has been researched along with Scleroderma, Diffuse in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Keyser, F; Decuman, S; Elewaut, D; Naeyaert, JM; Smith, V; Van der Cruyssen, B; Van Praet, JT; Vandooren, B1
Eltahir, A; Harney, S; Henry, M; MacEneaney, P; McLaughlin, P; Sinnot, C; Stack, J1
De Keyser, F; Decuman, S; Deschepper, E; Elewaut, D; Piette, Y; Smith, V; van Praet, JT1
Englert, H; Katelaris, C; McGill, N; Moore, J; Schrieber, L1
Banno, S; Hayami, Y; Maeda, S; Morita, A; Naniwa, T; Osawa, T; Sawada, H; Ueda, R; Watanabe, Y1

Trials

1 trial(s) available for methylprednisolone and Scleroderma, Diffuse

ArticleYear
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:1

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Rituximab; Scleroderma, Diffuse; Severity of Illness Index; Treatment Outcome; Young Adult

2010

Other Studies

4 other study(ies) available for methylprednisolone and Scleroderma, Diffuse

ArticleYear
Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone.
    Scandinavian journal of rheumatology, 2010, Volume: 39, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myocarditis; Scleroderma, Diffuse; Treatment Outcome

2010
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.
    The Journal of rheumatology, 2013, Volume: 40, Issue:1

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Middle Aged; Pilot Projects; Rituximab; Scleroderma, Diffuse; Severity of Illness Index; Skin; Treatment Outcome

2013
'Grape-sultana' sign represents a favourable response to aggressive treatment of early diffuse systemic scleroderma.
    Internal medicine journal, 2005, Volume: 35, Issue:7

    Topics: Adult; Bone Marrow Transplantation; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hyperpigmentation; Immunosuppressive Agents; Methylprednisolone; Scleroderma, Diffuse

2005
Drug-induced hypersensitivity syndrome associated with a marked increase in anti-paramyxovirus antibody titers in a scleroderma patient.
    Allergology international : official journal of the Japanese Society of Allergology, 2007, Volume: 56, Issue:3

    Topics: Anti-Inflammatory Agents; Antibodies, Viral; Drug Hypersensitivity; Humans; Male; Methylprednisolone; Middle Aged; Parainfluenza Virus 2, Human; Paramyxoviridae Infections; Scleroderma, Diffuse; Trimethoprim, Sulfamethoxazole Drug Combination

2007